Bugleweed - Drug Interactions, Side Effects and Precautions of Use
Common Trade Names
Bugleweed Extract, Bugleweed Motherwort Compound
Available as a dried herb, liquid extract, and tincture.
Pharmacologically active compounds are extracted from the roots, stems, leaves, and flowers of Lycopus virginicus and Lycopus europaeus. These members of the mint family are native to Europe and North America.
Active constituents of L. europaeus include lithospermic, chlorogenic, caffeic, ellagic, and rosmarinic acids as well as the flavone glycoside luteolin7-glucoside. Other compounds include amino acids, minerals, sugars, tannin, ursolic acid, and sinapinic acid. L. virginicus was found to contain rosmarinic and caffeic acids. L. europaeus was found to contain catechol oxidase from diterpene metabolites.
Certain active compounds in Lycopus species have demonstrated complex endocrine effects in animal models, including a dose-related decrease in immunoglobulin G (IgG) antibody activity. The plant also inhibits IgG stimulation of adenylate cyclase in human thyroid membranes and thyroid iodine release in mice in vivo. It is unclear why bugleweed extracts interact with thyroid-stimulating hormone (TSH) and IgG antibody activity.
A study in horses found that oxidized Lycopus plant constituents inhibited serum gonadotropin levels in pregnant mares. These constituents also inhibited human chorionic gonadotropin (HCG) and prolactin in vitro .
Bugleweed is claimed to have astringent and mild narcotic qualities and has been used for years in the symptomatic treatment of Graves' disease. Lycopus was compared with digitalis during the 19th century and was found to lower the pulse rate without accumulating in the system. .L. europaeus has also been used as a remedy for intermittent fever.
For antithyroidal and antigonadal effects, 25 to 50 mg/kg parenterally or 200 to 1,000 mg/kg P.O. in animals .
Metabolic: hyperthyroidism (controversial).
Beta blockers: May mask symptoms of hyperthyroidism. Avoid administration with bugleweed.
Thyroid hormone replacement: May interfere with thyroid replacement therapy. Avoid administration with bugleweed.
Contraindications And Precautions
Bugleweed is contraindicated in pregnant or breast-feeding patients; effects are unknown. Use with extreme caution in patients with primary or secondary hypopituitarism, pituitary adenoma, primary or secondary hypogonadism, TSH-stimulating tumors, or related disorders. Use cautiously in patients with systolic dysfunction or heart failure.
Points of Interest
L. europaeus is frequently sold as L. virginicus.
Knowledge of bugleweed's physiologic effects is derived from in vivo and in vitro animal studies using freeze-dried extracts. Although the results of animal studies do not necessarily apply to humans, they should inspire caution. This agent inhibits various hormones, such as FSH, TSH, LH, and HCq, but the level of inhibition has not been evaluated. It is difficult to determine the place, if any, of bugleweed in the treatment of Graves' disease, but research suggests that this plant should be investigated more thoroughly.
HEALTH CARE | ABOUT US | CONTACT US | BLOG
© 2005 Online-Health-Care.com. All rights reserved.
Disclaimer: Online-Health-Care.com is for informational purposes only and is not intended to act as a substitute for a professional healthcare practitioner advise. For specific medical advice, diagnoses, and treatment, please consult your doctor. We will not be liable for any complications, injuries or other medical accidents arising from or in connection with the use of or reliance upon any information on this web site.